BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 9564823)

  • 1. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Chesnokova V; Melmed S
    Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
    Chesnokova V; Auernhammer CJ; Melmed S
    Endocrinology; 1998 May; 139(5):2209-16. PubMed ID: 9564824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
    Chesnokova V; Melmed S
    Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V; Kariagina A; Melmed S
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion.
    Akita S; Malkin J; Melmed S
    Endocrinology; 1996 Jul; 137(7):3140-3. PubMed ID: 8770940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary cytokine network.
    Kariagina A; Romanenko D; Ren SG; Chesnokova V
    Endocrinology; 2004 Jan; 145(1):104-12. PubMed ID: 14512435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
    Akita S; Conn PM; Melmed S
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4170-8. PubMed ID: 8923879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW; Ren SG; Melmed S
    J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development.
    Yano H; Readhead C; Nakashima M; Ren SG; Melmed S
    Mol Endocrinol; 1998 Nov; 12(11):1708-20. PubMed ID: 9817597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia.
    Hadid R; Spinedi E; Chautard T; Giacomini M; Gaillard RC
    Neuroimmunomodulation; 1999; 6(5):336-43. PubMed ID: 10474052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.
    Li QL; Yano H; Ren SG; Li X; Friedman TC; Melmed S
    Endocrine; 1997 Dec; 7(3):325-30. PubMed ID: 9657069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
    Akita S; Webster J; Ren SG; Takino H; Said J; Zand O; Melmed S
    J Clin Invest; 1995 Mar; 95(3):1288-98. PubMed ID: 7883977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
    Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
    J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
    Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells.
    Göllner G; Bug G; Rupilius B; Peschel C; Huber C; Derigs HG
    Cytokine; 1999 Sep; 11(9):656-63. PubMed ID: 10479401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface.
    Wang Z; Ren SG; Melmed S
    Endocrinology; 1996 Jul; 137(7):2947-53. PubMed ID: 8770918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effect of leukemia inhibitory factor on ACTH secretion of dispersed rat pituitary cells.
    Kim DS; Melmed S
    Endocr Res; 1999 Feb; 25(1):11-9. PubMed ID: 10098589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.